EUVIMEDEUVIMED entdecken
Crossref

Relation of ICAM-1 and VCAM-1 markers in COVID-19 patients in Kirkuk province

Zubaida Najat Mustafa Albarzanji, Nuha Mumin Wahid, Najlaa Bakir Shaker, Zaid Mohammed Al-Bayati

Human Antibodies · 2024

DOI: 10.3233/hab-240027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Antibodies, 2024. Verfasst von Zubaida Najat Mustafa Albarzanji und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Kirkuk, College of Dentistry, Kirkuk, Iraq. Hauptthemen laut MEDLINE: Biomarkers, COVID-19, Intercellular Adhesion Molecule-1, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The advent of the Coronavirus Disease 2019 (COVID-19) has presented a substantial and urgent global public health issue. Biomarkers have the potential to be utilized for the identification of endothelium and/or alveolar epithelial damage in instances of COVID-19 infection. AIM OF THE STUDY: to evaluate the levels of Intercellular adhesion molecule-1 (ICAM-1) and Vascular cell adhesion molecule (VCAM-1) biomarkers in hospitalized patients who tested positive for COVID-19 infection using Polymerase Chain Reaction (PCR) with the virus specific Immunoglobulins; IgM, and IgG testing. This can help with improved clinical management and treatment programs. METHODS: A case-control study that involved 90 hospitalized patients who tested positive for COVID-19 and 40 apparently healthy control patients, subjects in both groups underwent nasopharyngeal swabs for PCR and blood sample collection for evaluation of serum; IgM, IgG, ICAM-1 and VCAM-1 levels. RESULTS: Males made up the vast majority of the patients (78.9%), with only a minor percentage of females (21.1%) [Formula: see text] value 0.1641. Furthermore, every patient in this study had a minimum of one risk factor for COVID-19. The investigator’s results show that COVID-19 patients had higher amounts of endothelial cell adhesion indicators (ICAM-1 and VCAM-1) with mean values of 126.27 [Formula: see text] 89.51 ng/mL and 109.74 [Formula: see text] 96.57 ng/mL respectively. While, ICAM-1 and VCAM-1, were present at normal levels in the control group with difference [Formula: see text] value 0.0028 and 0.0032 in comparison to the patient’s group respectively. CONCLUSIONS: The adhesive markers ICAM and VCAM play a crucial role in the development of COVID-19 and the strong endothelial activation and dysfunction linked to both acute and persistent immunological responses is shown by the substantial correlation found in COVID-19 patients between the presence of IgM and IgG antibodies and higher levels of ICAM-1 and VCAM-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersCOVID-19Intercellular Adhesion Molecule-1SARS-CoV-2Vascular Cell Adhesion Molecule-1AdultAgedFemaleHumansMaleMiddle AgedAntibodies, ViralCase-Control StudiesImmunoglobulin GImmunoglobulin M

Stichwörter der Autor:innen

COVID-19ICAM-1IgM/IgG antibodyRS-CoV-2VCAM-1

Substanzen

Antibodies, ViralBiomarkersICAM1 protein, humanImmunoglobulin GImmunoglobulin MIntercellular Adhesion Molecule-1Vascular Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • University of Kirkuk, College of Dentistry, Kirkuk, Iraq.
  • Al-Kitab University, Kirkuk, Iraq.
  • University of Liverpool, Liverpool, UK.
  • Azadi Teaching Hospital, Kirkuk, Iraq.

Zitieren

APA

Albarzanji, Z. N. M., Wahid, N. M., Shaker, N. B., & Al-Bayati, Z. M. (2024). Relation of ICAM-1 and VCAM-1 markers in COVID-19 patients in Kirkuk province. Human Antibodies. https://doi.org/10.3233/hab-240027

Vancouver

Albarzanji ZNM, Wahid NM, Shaker NB, Al-Bayati ZM. Relation of ICAM-1 and VCAM-1 markers in COVID-19 patients in Kirkuk province. Human Antibodies. 2024. doi:10.3233/hab-240027

BibTeX
@article{Albarzanji2024,
  author = {Albarzanji, Zubaida Najat Mustafa and Wahid, Nuha Mumin and Shaker, Najlaa Bakir and Al-Bayati, Zaid Mohammed},
  title = {Relation of ICAM-1 and VCAM-1 markers in COVID-19 patients in Kirkuk province},
  journal = {Human Antibodies},
  year = {2024},
  doi = {10.3233/hab-240027}
}
Kostenlos starten →